Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 150 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Tanezumab for cancer pain due to bone metastasis	Tanezumab (PF-04383119; RN624)	Cancer pain	Bone and Cartilage Cancer , Oncology	2020	View \| Download
Tecarfarin for preventing venous thromboembolism	Tecarfarin (ATI-5923)	Thromboembolism	Cardiovascular System , Haematology	2020	View \| Download
Tepotinib for advanced non-small cell lung cancer harbouring MET exon14- skipping mutations	Tepotinib (MSC-2156119J; TEPMETKO)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2020	View \| Download
Tezepelumab for severe, uncontrolled asthma	Tezepelumab (AMG 157; MEDI9929)	Asthma	Respiratory System	2020	View \| Download
Tideglusib for congenital myotonic dystrophy	Tideglusib (AMO-02; Zentylor; Nypta; NP031112)	Myotonic dystrophy	Genetic Disorders , Musculoskeletal System , Neurology	2020	View \| Download
Timrepigene emparvovec for choroideremia	Timrepigene emparvovec (BIIB111; AAV2-REP1; NSR-REP1)	Choroideremia	Ophthalmology	2020	View \| Download
Tofacitinib for Ankylosing Spondylitis	Tofacitinib citrate (Xeljanz; CP-690550)	Ankylosing spondylitis	Musculoskeletal System	2020	View \| Download
Tofersen for the treatment of amyotrophic lateral sclerosis caused by mutations in the SOD1 gene	Tofersen sodium (BIIB067)	Motor neurone disease (MND or ALS)	Neurology	2020	View \| Download
Tralesinidase alfa for mucopolysaccharidosis type IIIB (Sanfilippo syndrome type B)	Tralesinidase alfa (BMN 250)	Mucopolysaccharidosis type IIIB (Sanfilippo B syndrome)	Endocrine Nutritional and Metabolic Disorders	2020	View \| Download
Tralokinumab for adolescents with moderate to severe atopic dermatitis	Tralokinumab (CAT-354; LP 0162)	Atopic dermatitis	Dermatology	2020	View \| Download